March 22, 2023 Meeting Of The Peripheral And Central Nervous System Drugs Advisory Committee

March 22, 2023 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)

U.S. Food and Drug Administration

June 9, 2023 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)

U.S. Food and Drug Administration

June 10, 2024 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)

U.S. Food and Drug Administration

March 30, 2022 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee

U.S. Food and Drug Administration

September 7, 2022 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee

U.S. Food and Drug Administration

March 16, 2023 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)

U.S. Food and Drug Administration

January 24, 2023 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)

U.S. Food and Drug Administration

Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

April 28, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

February 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

March 9, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

September 22-23, 2022 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - Day 2

U.S. Food and Drug Administration

March 15, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

Oncologic Drugs Advisory Committee Meeting

U.S. Food and Drug Administration

May 11, 2023 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)

U.S. Food and Drug Administration

Intro to FDA Advisory Committee meetings: aducanumab's AdComm

October 28, 2022 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration

Treating Cancers of the Central Nervous System

June 4, 2024 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)

U.S. Food and Drug Administration

November 16, 2023 Meeting of the Oncologic Drugs Advisory Committee (ODAC)

U.S. Food and Drug Administration